Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1999 1
2000 2
2001 2
2002 3
2003 2
2004 6
2005 6
2006 6
2007 18
2008 17
2009 39
2010 3
2011 2
2012 2
2013 3
2014 1
2016 1
2017 2
2018 4
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19104437

115 results
Results by year
Filters applied: . Clear all
Page 1
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer.
Turner J, Chaudhary U. Turner J, et al. Anticancer Drugs. 2009 Mar;20(3):215-6. doi: 10.1097/CAD.0b013e3283163c26. Anticancer Drugs. 2009. PMID: 19104437
Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
Soga N, Arima K, Sugimura Y. Soga N, et al. Jpn J Clin Oncol. 2008 Sep;38(9):617-22. doi: 10.1093/jjco/hyn071. Epub 2008 Aug 12. Jpn J Clin Oncol. 2008. PMID: 18697759 Clinical Trial.
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.
Sartor O, Gomella LG, Gagnier P, Melich K, Dann R. Sartor O, et al. Can J Urol. 2009 Oct;16(5):4806-12. Can J Urol. 2009. PMID: 19796455 Clinical Trial.
Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
Nemoto K, Tomita Y. Nemoto K, et al. Scand J Urol Nephrol. 2007;41(6):558-60. doi: 10.1080/00365590701365404. Scand J Urol Nephrol. 2007. PMID: 17853028
Multimodality imaging in biochemical recurrence of prostate cancer: utility of (18)F-NaF PET/CT in early detection of metastasis.
Desai B, Gross ME, Jadvar H. Desai B, et al. Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):231-2. doi: 10.1016/j.remn.2012.03.008. Epub 2012 May 14. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 22980132 Free PMC article. No abstract available.
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Gandhok N, Sartor O. Gandhok N, et al. Urology. 2004 Oct;64(4):807-9. doi: 10.1016/j.urology.2004.05.042. Urology. 2004. PMID: 15491730
Complete remission of metastatic carcinoma of the prostate with bicalutamide withdrawal.
Kundranda MN, Muslimani A, Daw HA, Spiro TP. Kundranda MN, et al. Clin Genitourin Cancer. 2007 Sep;5(6):401-2. doi: 10.3816/CGC.2007.n.024. Clin Genitourin Cancer. 2007. PMID: 17956714
Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
Moul JW. Moul JW. Cancer. 2009 Aug 1;115(15):3376-8. doi: 10.1002/cncr.24393. Cancer. 2009. PMID: 19484788 Free article. No abstract available.
[Results of 125-iodine seed implant with preplanning system in 250 patients with prostate cancer].
Guinot JL, Ricós JV, Gimeno J, Tortajada MI, Carrascosa M, Santos M, Casanova J, Soler P, Crispín V, Arribas L. Guinot JL, et al. Actas Urol Esp. 2011 Jun;35(6):339-44. doi: 10.1016/j.acuro.2011.02.003. Epub 2011 Apr 8. Actas Urol Esp. 2011. PMID: 21481974 Spanish.
Biochemical remission after resection of prostate cancer lung metastasis.
Chao DH, Higgins JP, Brooks JD. Chao DH, et al. Urology. 2004 Mar;63(3):584-5. doi: 10.1016/j.urology.2003.10.069. Urology. 2004. PMID: 15028469
115 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page